Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20316
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnderson, David B-
dc.contributor.authorFerreira, Manuela L-
dc.contributor.authorHarris, Ian A-
dc.contributor.authorDavis, Gavin A-
dc.contributor.authorStanford, Ralph-
dc.contributor.authorBeard, David-
dc.contributor.authorLi, Qiang-
dc.contributor.authorJan, Stephen-
dc.contributor.authorMobbs, Ralph J-
dc.contributor.authorMaher, Christopher G-
dc.contributor.authorYong, Renata-
dc.contributor.authorZammit, Tara-
dc.contributor.authorLatimer, Jane-
dc.contributor.authorBuchbinder, Rachelle-
dc.date2019-02-13-
dc.date.accessioned2019-03-04T22:04:16Z-
dc.date.available2019-03-04T22:04:16Z-
dc.date.issued2019-02-13-
dc.identifier.citationBMJ Open 2019; 9(2): e024944-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20316-
dc.description.abstractCentral lumbar spinal stenosis (LSS) is a common cause of pain, reduced function and quality of life in older adults. Current management of LSS includes surgery to decompress the spinal canal and alleviate symptoms. However, evidence supporting surgical decompression derives from unblinded randomised trials with high cross-over rates or cohort studies showing modest benefits. This protocol describes the design of the SUrgery for Spinal Stenosis (SUcceSS) trial -the first randomised placebo-controlled trial of decompressive surgery for symptomatic LSS. SUcceSS will be a prospectively registered, randomised placebo-controlled trial of decompressive spinal surgery. 160 eligible participants (80 participants/group) with symptomatic LSS will be randomised to either surgical spinal decompression or placebo surgical intervention. The placebo surgical intervention is identical to surgical decompression in all other ways with the exception of the removal of any bone or ligament. All participants and assessors will be blinded to treatment allocation. Outcomes will be assessed at baseline and at 3, 6, 12 and 24 months. The coprimary outcomes will be function measured with the Oswestry Disability Index and the proportion of participants who have meaningfully improved their walking capacity at 3 months postrandomisation. Secondary outcomes include back pain intensity, lower limb pain intensity, disability, quality of life, anxiety and depression, neurogenic claudication score, perceived recovery, treatment satisfaction, adverse events, reoperation rate and rehospitalisation rate. Those who decline to be randomised will be invited to participate in a parallel observational cohort. Data analysis will be blinded and by intention to treat. A trial-based cost-effectiveness analysis will determine the potential incremental cost per quality-adjusted life year gained. Ethics approval has been granted by the NSW Health (reference:17/247/POWH/601) and the Monash University (reference: 12371) Human Research Ethics Committees. Dissemination of results will be via journal articles and presentations at national and international conferences. ACTRN12617000884303; Pre-results.-
dc.language.isoeng-
dc.subjectlumbar spinal stenosis-
dc.subjectplacebo controlled trial-
dc.subjectrandomised controlled trial-
dc.titleSUcceSS, SUrgery for Spinal Stenosis: protocol of a randomised, placebo-controlled trial.-
dc.typeJournal Article-
dc.identifier.journaltitleBMJ Open-
dc.identifier.affiliationInsitute of Bone and Joint Research, The Kolling Institute, University of Sydney, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Neurosurgery, Cabrini Hospital, Malvern, Victoria, Australiaen
dc.identifier.affiliationWhitlam Orthopaedic Research Centre, Ingham Institute for Applied Medical Research, University of New South Wales, St Leonards, New South Wales, Australiaen
dc.identifier.affiliationNuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Science, NIHR Biomedical Research Unit, University of Oxford, Oxford, UKen
dc.identifier.affiliationThe George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australiaen
dc.identifier.affiliationMonash Department of Clinical Epidemiology, Cabrini Institute, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationSchool of Public Health, The University of Sydney, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Orthopaedic Surgery, Prince of Wales Hospital, Randwick, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Neurosurgery, Prince of Wales Private Hospital, Randwick, New South Wales, Australiaen
dc.identifier.affiliationNeuroSpine Surgery Research Group (NSURG), Prince of Wales Private Hospital, Sydney, New South Wales, Australiaen
dc.identifier.affiliationDepartment of Neurosurgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1136/bmjopen-2018-024944-
dc.identifier.pubmedid30765407-
dc.type.austinJournal Article-
local.name.researcherDavis, Gavin A
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptNeurosurgery-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

36
checked on Oct 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.